pubmed.ncbi.nlm.nih.gov

Zinc for the common cold - PubMed

️Sat Jan 01 2011

Review

Zinc for the common cold

Meenu Singh et al. Cochrane Database Syst Rev. 2011.

Update in

Zinc for the common cold.

Singh M, Das RR. Singh M, et al. Cochrane Database Syst Rev. 2013 Jun 18;(6):CD001364. doi: 10.1002/14651858.CD001364.pub4. Cochrane Database Syst Rev. 2013. PMID: 23775705 Updated. Review.

Abstract

Background: The common cold is one of the most widespread illnesses and is a leading cause of visits to the doctor and absenteeism from school and work. Trials conducted since 1984 investigating the role of zinc for the common cold symptoms have had mixed results. Inadequate treatment masking and reduced bioavailability of zinc from some formulations have been cited as influencing results.

Objectives: To assess the effect of zinc on common cold symptoms.

Search strategy: We searched CENTRAL (2010, Issue 2) which contains the Acute Respiratory Infections Group's Specialised Register, MEDLINE (1966 to May week 3, 2010) and EMBASE (1974 to June 2010).

Selection criteria: Randomised, double-blind, placebo-controlled trials using zinc for at least five consecutive days to treat, or for at least five months to prevent the common cold.

Data collection and analysis: Two review authors independently extracted data and assessed trial quality.

Main results: We included 13 therapeutic trials (966 participants) and two preventive trials (394 participants). Intake of zinc is associated with a significant reduction in the duration (standardized mean difference (SMD) -0.97; 95% confidence interval (CI) -1.56 to -0.38) (P = 0.001), and severity of common cold symptoms (SMD -0.39; 95% CI -0.77 to -0.02) (P = 0.04). There was a significant difference between the zinc and control group for the proportion of participants symptomatic after seven days of treatment (OR 0.45; 95% CI 0.2 to 1.00) (P = 0.05). The incidence rate ratio (IRR) of developing a cold (IRR 0.64; 95% CI 0.47 to 0.88) (P = 0.006), school absence (P = 0.0003) and prescription of antibiotics (P < 0.00001) was lower in the zinc group. Overall adverse events (OR 1.59; 95% CI 0.97 to 2.58) (P = 0.06), bad taste (OR 2.64; 95% CI 1.91 to 3.64) (P < 0.00001) and nausea (OR 2.15; 95% CI 1.44 to 3.23) (P = 0.002) were higher in the zinc group.

Authors' conclusions: Zinc administered within 24 hours of onset of symptoms reduces the duration and severity of the common cold in healthy people. When supplemented for at least five months, it reduces cold incidence, school absenteeism and prescription of antibiotics in children. There is potential for zinc lozenges to produce side effects. In view of this and the differences in study populations, dosages, formulations and duration of treatment, it is difficult to make firm recommendations about the dose, formulation and duration that should be used.

PubMed Disclaimer

Update of

WITHDRAWN: Zinc for the common cold.

Marshall I. Marshall I. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD001364. doi: 10.1002/14651858.CD001364.pub2. Cochrane Database Syst Rev. 2007. PMID: 17636670 Updated. Review.

Cited by

Intranasal ipratropium bromide for the common cold.
AlBalawi ZH, Othman SS, Alfaleh K. AlBalawi ZH, et al. Cochrane Database Syst Rev. 2013 Jun 19;2013(6):CD008231. doi: 10.1002/14651858.CD008231.pub3. Cochrane Database Syst Rev. 2013. PMID: 23784858 Free PMC article. Review.
Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection: The COVID A to Z Randomized Clinical Trial.
Thomas S, Patel D, Bittel B, Wolski K, Wang Q, Kumar A, Il'Giovine ZJ, Mehra R, McWilliams C, Nissen SE, Desai MY. Thomas S, et al. JAMA Netw Open. 2021 Feb 1;4(2):e210369. doi: 10.1001/jamanetworkopen.2021.0369. JAMA Netw Open. 2021. PMID: 33576820 Free PMC article. Clinical Trial.
PURLs: Zinc for the common cold--not if, but when.
Rao G, Rowland K. Rao G, et al. J Fam Pract. 2011 Nov;60(11):669-71. J Fam Pract. 2011. PMID: 22049349 Free PMC article.
Immunological aspects of sport nutrition.
Gleeson M. Gleeson M. Immunol Cell Biol. 2016 Feb;94(2):117-23. doi: 10.1038/icb.2015.109. Epub 2015 Dec 4. Immunol Cell Biol. 2016. PMID: 26634839 Review.
Complementary and integrative treatments: upper respiratory infection.
Weiss JR, Tessema B, Brown SM. Weiss JR, et al. Otolaryngol Clin North Am. 2013 Jun;46(3):335-44. doi: 10.1016/j.otc.2012.12.007. Epub 2013 Feb 12. Otolaryngol Clin North Am. 2013. PMID: 23764813 Free PMC article. Review.

Zinc for the common cold - PubMed